Cedar Brook Financial Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,668
| Closed | -$218K | – | 366 |
|
|
2022
Q1 | $218K | Buy |
3,668
+256
| +8% | +$15.2K | 0.06% | 344 |
|
|
2021
Q4 | $248K | Buy |
3,412
+438
| +15% | +$31.8K | 0.06% | 320 |
|
|
2021
Q3 | $208K | Buy |
2,974
+29
| +1% | +$2.03K | 0.06% | 325 |
|
|
2021
Q2 | $203K | Buy |
+2,945
| New | +$203K | 0.06% | 355 |
|
|
2020
Q4 | – | Sell |
-3,500
| Closed | -$221K | – | 329 |
|
|
2020
Q3 | $221K | Sell |
3,500
-524
| -13% | -$33.1K | 0.09% | 255 |
|
|
2020
Q2 | $310K | Sell |
4,024
-182
| -4% | -$14K | 0.14% | 185 |
|
|
2020
Q1 | $314K | Buy |
+4,206
| New | +$314K | 0.17% | 164 |
|
|
2019
Q4 | – | Sell |
-4,263
| Closed | -$270K | – | 304 |
|
|
2019
Q3 | $270K | Buy |
4,263
+246
| +6% | +$15.6K | 0.12% | 220 |
|
|
2019
Q2 | $271K | Buy |
4,017
+86
| +2% | +$5.8K | 0.13% | 223 |
|
|
2019
Q1 | $256K | Buy |
+3,931
| New | +$256K | 0.12% | 221 |
|